478
Participants
Start Date
October 27, 2021
Primary Completion Date
January 12, 2026
Study Completion Date
December 31, 2029
Mosunetuzumab
Participants will receive intravenous (IV) mosunetuzumab in a step-up dosing schedule on Days 1, 8, and 15 of Cycle 1, and on Day 1 of Cycles 2-12
Lenalidomide
Participants will receive oral lenalidomide once daily on Days 1-21 of Cycles 2-12 (M + Len) or Cycles 1-12 (R + Len)
Rituximab
Participants will receive IV rituximab on Days 1, 8, 15, and 22 of Cycle 1, then on Day 1 of Cycles 3, 5, 7, 9, and 11
Tociluzumab
Tocilizumab will be administered as needed to manage cytokine release syndrome (CRS) events
National Taiwan Universtiy Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Chang Gung Medical Foundation - Linkou, Taoyuan District
Chang Gung Medical Foundation - Kaohsiung;Oncology, Kaoisung
Calvary Mater Newcastle, Waratah
Geelong Hospital, Geelong
Princess Alexandra Hospital Woolloongabba, Woolloongabba
Royal Adelaide Hospital, Adelaide
NYU Langone Ambulatory Care Center, New York
Montefiore Medical Center - Montefiore Medical Park, The Bronx
Montefiore Medical Center, The Bronx
Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie, Berlin
NYU Long Island Hospital, Mineola
Institut Paoli Calmettes, Marseille
Seoul National University Bundang Hospital, Seongnam-si
Universitätsklinik Rostock, Rostock
Hospital de Donostia, Guipuzcoa
Johns Hopkins Uni, Baltimore
Wake Forest Univ Health Svcs, Winston-Salem
Duke University Medical Center, Durham
Hospital Universitario la Paz, Madrid
Hospital General Universitario J.M Morales Meseguer, Murcia
CHU de Nîmes - Hôpital Carémeau, Nîmes
Winship Cancer Institute, Atlanta
Hopital De Haut Leveque, Pessac
CHU Saint Eloi, Montpellier
Atakent Acibadem Private Hosptial Halkali Merkez Mh.,, Istanbul
Koc Universitesi (KU) Tip Fakultesi (Koc University School of Medicine), Sarıyer
CHU Pontchaillou, Rennes
Ematologia/immunologia Clinica Azienda Ospedaliera Policlinico di Padova, Padua
A.O. Universitaria Policlinico S.Orsola-Malpighi Di Bologna, Bologna
Hospital Universitario Virgen del Rocio, Seville
CHU NANTES - Hôtel Dieu, Nantes
Hospital Clinico Universitario de Valencia, Valencia
Investigative Clinical Research of Indiana, LLC, Noblesville
Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
University of Michigan Health System, Ann Arbor
U.O. Ematologia AUSL Ravenna, Ravenna
Pusan National University Hospital, Busan
Cancer & Hematology Center of West Michigan, Grand Rapids
Azienda Ospedaliera Universitaria Careggi, Florence
CHU de Reims, Reims
Hopital Claude Huriez, Lille
Ospedali Riuniti Umberto I, Ancona
Washington University, St Louis
Centre Hospitalier de La Cote Basque, Bayonne
ICANS, Strasbourg
Uniklinik Heidelberg, Medizinische Klinik & Poliklinik V, Heidelberg
Ch Lyon Sud, Pierre-Bénite
Ch De Chambery, Chambéry
Baylor University Medical Center, Dallas
Hôpital Saint-Louis, Paris
Hopital Saint Antoine, Paris
Centre Henri Becquerel, Rouen
MD Anderson Cancer Center, Houston
Hopital De La Miletrie, Poitiers
Universtitätsklinikum Ulm, Ulm
Ospedale V. Cervello, Palermo
City of Hope Comprehensive Cancer Center, Duarte
Klinik und Poliklinik f. Innere Medizin III des Universitätsklinikums Regensburg, Regensburg
Hopital Henri Mondor, Créteil
Peking University First Hospital, Beijing
Beijing Cancer Hospital, Beijing
Peking University Third Hospital, Beijing
City Clinical Botkin's Hospital, Moscow
The First Hospital of Jilin University, Changchun
Harbin Medical University Cancer Hospital, Harbin
Fudan University Shanghai Cancer Center, Shanghai
Jiangsu Province Hospital, Nanjing
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin
Zhejiang Cancer Hospital, Zhejiang
The 1st Affiliated Hospital of Nanchang Unversity, Nanchang
The First Affiliated Hospital of Xiamen University, Xiamen
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
Penza Regional Oncology Dispensary, Penza
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Cancer Center, Sun Yat-sen University of Medical Sciences, Guangzhou
Kadlec Clinic Hematology and Oncology, Kennewick
ICTR Curitiba, Curitiba
Hospital das Clinicas - UFRGS, Porto Alegre
Hospital Mae de Deus, Porto Alegre
Hospital Alemao Oswaldo Cruz, São Paulo
Centre Antoine Lacassagne, Nice
BAG Freiberg-Richter, Jacobasch, Illmer, Wolf, Dresden
Universitätsklinikum Halle, Halle
Aichi Cancer Center, Aichi
National Cancer Center Hospital East, Chiba
University Hospital Kyoto Prefectural University of Medicine, Kyoto
Mie University Hospital, Mie
Tohoku University Hospital, Miyagi
Okayama University Hospital, Okayama
National Cancer Center Hospital, Tokyo
The Cancer Institute Hospital of JFCR, Tokyo
Uniwersyteckie Centrum Kliniczne, Gdansk
Szpitale Pomorskie Sp. z o. o., Gdynia
Pratia Onkologia Katowice, Katowice
Uniwersytecki Szpital Kliniczny w Poznaniu, Późna
Instytut Hematologii i Transfuzjologii, Warsaw
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroc?aw
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Seoul St Mary's Hospital, Seoul
Hacettepe Uni Medical Faculty, Ankara
Marmara Ün?Vers?Tes? ?Stanbul Pend?K E??T?M Ve Ara?Tirma Hastanes?, Istanbul
Royal Cornwall Hospitals NHS Trust, Cornwall
Gloucestershire Royal Hospital, Gloucester
Hammersmith Hospital, London
Nottingham City Hospital, Nottingham
Torbay Hospital, Torquay
Hoffmann-La Roche
INDUSTRY